Intelligence Platform
Patents
Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6433137
TUP1 sequences from Candida albicans and methods for screening agents for inhibiting virul
expired patentUS 6429208
Methods and compositions for restoring impaired cellular immune function
expired patentUS 6426086
pH-sensitive, serum-stable liposomes
expired patentUS 6426058
Enhancement of NMR and MRI in the presence of hyperpolarized noble gases
expired patentUS 6426336
Method for treating allergic lung disease
expired patentUS 6420428
Treatment and prevention of hepatic disorders
expired patentUS 6416759
Antiproliferative Sgk reagents and methods
expired patentUS 6413773
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
expired patentUS 6410249
Odorant receptors
expired patentUS 6410049
Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo d
expired patentUS 6409990
Macromolecular carrier for drug and diagnostic agent delivery
expired patentUS 6410721
Polynucleotide decoys that inhibit MHC-II expression and uses thereof
expired patentUS 6399580
Methods and compositions for stimulating tissue growth and epithelial moisturization
expired patentUS 6399762
Methods and compositions for diagnosing and treating chromosome -18p related disorders
expired patentUS 6395882
Selectin ligands
expired patentUS 6395709
Methods and compositions for stimulating tissue growth and epithelial moisturization
expired patentUS 6391848
Soybean protein nutraceuticals
expired patentUS 6391574
AFC1 and RCE1: isoprenylated CAAX processing enzymes
expired patentUS 6384015
Selective lysis of malaria infected erythrocytes
expired patentUS 6384191
Receptors for fibroblast growth factors
expired patentUS 6383764
Methods of identifying compounds for controlling absence seizures in a mammal relating to
expired patentUS 6383760
Transcriptionally regulated G protein-coupled receptor
expired patentUS 6380403
Illudin analogs useful as antitumor agents
expired patentUS 6380371
Endoglycan: a novel protein having selectin ligand and chemokine presentation activity
expired